Content is intended for people aged >18 years only
Under the UK Modern Slavery Act 2015, Allergan Limited publishes a Slavery and Human Trafficking Statement for each financial year, describing what steps we have taken to address the risk of slavery or human trafficking occurring in our own operations or our supply chains.
Adverse events should be reported. UK reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.
Irish healthcare professionals (HCPs) are asked to report any suspected adverse reactions via HPRA Pharmacovigilance; website https://www.hpra.ie. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
UK-AGNA-230236 Date of Preparation:- June 2024